Profile data is unavailable for this security.
About the company
China Isotope & Radiation Corporation is a China-based company mainly engaged in research, development, manufacturing and sales of radiopharmaceuticals and radioactive source products. The Company operates mainly through five segments. The Pharmaceuticals segment is mainly engaged in the manufacture and sales of various radiopharmaceuticals for imaging diagnosis and treatment, urea breath test kits and testers, as well as in vitro diagnostic reagents and kits. The Radioactive Source Product segment is mainly engaged in the production and sales of various radioactive source products, and provides related technical services. The Irradiation segment mainly provides irradiation sterilization services and others. The Radiotherapy Equipment and Related Services segment is mainly engaged in the research and development of radiotherapy equipment. The Independent Medical Laboratory Services and Other Business segment mainly provides independent medical laboratory services.
- Revenue in HKD (TTM)7.18bn
- Net income in HKD401.48m
- Incorporated1983
- Employees3.11k
- LocationChina Isotope & Radiation CorpNo. 66 Changwa Middle StreetHaidian DistrictBEIJING ChinaCHN
- Phone+86 1 068411265
- Fax+86 1 068512374
- Websitehttp://www.china-isotope.com/
More ▼
Mergers & acquisitions
| Acquired company | 1763:HKG since announced | Transaction value |
|---|---|---|
| Dalian CNNC Radiation Technology Co Ltd | -14.06% | 646.00k |
Data delayed at least 15 minutes, as of May 10 2024 08:57 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SinoMab Bioscience Ltd | 1.48m | -263.11m | 2.02bn | 233.00 | -- | 5.99 | -- | 1,367.22 | -0.2584 | -0.2584 | 0.0015 | 0.3091 | 0.0015 | -- | -- | -- | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -8.15 | 0.604 | -- | -- | -- | 14.45 | -- | -- | -- |
| Acotec Scientific Holdings Ltd | 512.82m | 15.68m | 2.02bn | 638.00 | 123.70 | 1.44 | 30.75 | 3.94 | 0.0521 | 0.0521 | 1.70 | 4.48 | 0.3136 | 0.7213 | 3.44 | 803,793.30 | 0.9589 | -- | 1.03 | -- | 79.65 | -- | 3.06 | -- | 9.12 | 2.75 | 0.1529 | -- | 19.80 | -- | -79.35 | -- | -- | -- |
| Cutia Therapeutics | 148.94m | -2.13bn | 2.16bn | 298.00 | -- | 1.47 | -- | 14.49 | -6.99 | -6.99 | 0.4899 | 4.80 | -- | -- | -- | 499,805.20 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Abbisko Cayman Ltd | 20.63m | -467.08m | 2.42bn | 258.00 | -- | 1.13 | -- | 117.44 | -0.7217 | -0.7217 | 0.0319 | 3.06 | 0.0083 | -- | 1.40 | 79,951.98 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
| Peijia Medical Ltd | 477.41m | -424.81m | 2.49bn | 1.04k | -- | 1.01 | -- | 5.21 | -0.6255 | -0.6255 | 0.7028 | 3.62 | 0.1473 | 0.7773 | 9.51 | 459,045.10 | -13.11 | -34.08 | -14.94 | -36.90 | 73.76 | 71.62 | -88.99 | -448.75 | 6.92 | -- | 0.0886 | -- | 75.86 | -- | 3.75 | -- | -- | -- |
| Frontage Holdings Corp | 2.03bn | 84.45m | 2.50bn | 1.76k | 30.10 | 0.9348 | 6.92 | 1.23 | 0.0409 | 0.0409 | 0.981 | 1.32 | 0.463 | 60.63 | 5.32 | 1,154,294.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Laekna Inc | 0.00 | -399.15m | 2.57bn | 89.00 | -- | 2.95 | -- | -- | -3.31 | -3.31 | 0.00 | 2.23 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
| MicroPort CardioFlow Medtech Corp | 363.87m | -510.32m | 2.75bn | 592.00 | -- | 1.09 | -- | 7.56 | -0.2159 | -0.2159 | 0.154 | 1.05 | 0.1205 | 2.78 | 3.67 | 614,640.80 | -16.91 | -17.37 | -18.11 | -22.96 | 2.06 | -1.67 | -140.25 | -180.82 | 9.91 | -11.56 | 0.0293 | -- | 33.94 | -- | -3.77 | -- | -14.16 | -- |
| Golden Throat Holdings Group Co Ltd | 1.04bn | 270.74m | 2.84bn | 869.00 | 10.49 | 1.69 | 9.07 | 2.73 | 0.3662 | 0.3662 | 1.41 | 2.27 | 0.4181 | 4.82 | 1.85 | 1,197,292.00 | 10.88 | 11.00 | 15.85 | 15.63 | 72.57 | 72.79 | 26.02 | 24.67 | 2.48 | 34.74 | 0.21 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| HighTide Therapeutics Inc | 0.00 | -594.96m | 3.48bn | 66.00 | -- | 4.20 | -- | -- | -1.26 | -1.26 | -- | 1.61 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -0.3798 | 0.0229 | -- | -- | -- | -393.76 | -- | -- | -- |
| China Isotope & Radiation Corp | 7.18bn | 401.48m | 3.52bn | 3.11k | 8.76 | 0.6927 | 3.24 | 0.49 | 1.26 | 1.26 | 22.45 | 15.88 | 0.5312 | 4.22 | 1.84 | 2,312,623.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 28.27 | 7.82 | 15.35 | -5.43 | 2.88 | 3.63 | 2.92 |
| CARsgen Therapeutics Holdings Ltd | 0.00 | -809.30m | 3.55bn | 516.00 | -- | 1.82 | -- | -- | -1.46 | -1.46 | 0.00 | 3.39 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 775.88m | -414.45m | 3.89bn | 1.07k | -- | 4.58 | -- | 5.02 | -1.04 | -1.04 | 1.95 | 2.13 | 0.2732 | 16.21 | 5.74 | 727,837.90 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 4.37bn | 1.93k | 254.19 | 1.04 | 38.57 | 0.8216 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -619.00m | 4.44bn | 472.00 | -- | 3.80 | -- | -- | -1.29 | -1.29 | 0.00 | 2.42 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Ocumension Therapeutics | 266.63m | -411.02m | 4.72bn | 444.00 | -- | 1.48 | -- | 17.71 | -0.6334 | -0.6334 | 0.4107 | 4.57 | 0.078 | 3.61 | 2.12 | 600,517.40 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
Data as of May 10 2024. Currency figures normalised to China Isotope & Radiation Corp's reporting currency: Hong Kong Dollar HKD
18.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesco Canada Ltd.as of 11 Jan 2023 | 4.43m | 5.54% |
| UBS Asset Management Switzerland AGas of 12 Dec 2023 | 3.70m | 4.62% |
| Invesco Hong Kong Ltd.as of 16 Jan 2023 | 3.38m | 4.23% |
| Invesco Advisers, Inc.as of 13 Jan 2023 | 2.22m | 2.77% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 377.40k | 0.47% |
| Lacuna Verm�gen GmbHas of 30 Jun 2021 | 270.00k | 0.34% |
| Dodge & Coxas of 31 Mar 2024 | 136.40k | 0.17% |
| Polunin Capital Partners Ltd.as of 30 Jun 2023 | 61.93k | 0.08% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 33.04k | 0.04% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 30.20k | 0.04% |
More ▼
Data from 30 Jun 2021 - 09 May 2024Source: FactSet Research Systems Inc.
